SECSONAR

$AKBA

Akebia Therapeutics, Inc.

NASDAQ

Down 6% since last report

72% below 52-week high

FCF positive · Revenue growing

Price

52-week range $0.80 – $4.01

52w low $0.80Now $1.11

Find before everyone else

SEC filings, insider trades & earnings for AKBA — in one place.